CordenPharma announces €500m facility in Switzerland to boost peptide manufacturing
This initiative forms part of the Swiss CDMO's wider plan to enhance its peptide platform, aiming for sales surpassing €1bn by 2028
FDA accepts supplemental biologics license application for Roche’s Gazyva/Gazyvaro for treatment of lupus nephritis
WuXi Biologics introduces EffiX to enhance recombinant protein and DNA production
BeiGene gets FDA approval for Tevimbra plus chemo to treat oesophageal cancer
Garuda secures $50m financing to boost stem cell therapies
FairJourney Biologics acquires Charles River Laboratories South San Francisco facility
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry